Relmada Therapeutics
RLMD
0,25 €
Share price
-5.76%
Change (1 day)
-95.60%
Change (1 year)
Categories
Relmada Therapeutics (RLMD) - Total liabilities
Total liabilities on the balance sheet as of September 2024 : €7.79 Million
According to Relmada Therapeutics's latest financial reports the company's total liabilities are €7.79 Million. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Relmada Therapeutics - Total liabilities on balance sheet (from 2012 to 2024)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | €11.62 M | -12.59% |
| 2021-12-31 | €13.29 M | 29.78% |
| 2020-12-31 | €10.24 M | |
| 2019-06-30 | €2.28 M | -68.72% |
| 2018-06-30 | €7.31 M | 507.97% |
| 2017-06-30 | €1.2 M | -58.18% |
| 2016-06-30 | €2.87 M | -79.28% |
| 2015-06-30 | €13.88 M | -29.5% |
| 2014-06-30 | €19.69 M | |
| 2013-08-31 | €0.02 M | 355.72% |
| 2012-08-31 | €0 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 | €0.36 B | 4,642.20% | 🇮🇱 Israel |
 | €1.39 B | 17,802.37% | 🇺🇸 USA |